Ad
related to: heterozygous factor v leiden deficiency- Patient Resources
Find helpful resources and videos
for rare bleeding disorders.
- Bleeding Emergencies
Learn how you can prepare for
bleeding emergencies.
- Blood Clots & Coagulation
A quick look at bleeding disorders.
Learn about the basics.
- Managing Dental Care
Oral and dental health matters.
Considerations for dental care.
- Patient Resources
Search results
Results from the WOW.Com Content Network
Pathophysiology of factor V Leiden gene mutation. Factor V Leiden is an autosomal dominant genetic condition that exhibits incomplete penetrance, i.e. not every person who has the mutation develops the disease. The condition results in a factor V variant that cannot be as easily degraded by activated protein C.
However, people with homozygous factor V Leiden, and people with heterozygous factor V Leiden who have an additional thrombophilic condition (e.g., antithrombin deficiency, protein C deficiency, or protein S deficiency), should be considered for lifelong oral anticoagulation therapy. [17]
14067 Ensembl ENSG00000198734 ENSMUSG00000026579 UniProt P12259 O88783 RefSeq (mRNA) NM_000130 NM_007976 RefSeq (protein) NP_000121 NP_032002 Location (UCSC) Chr 1: 169.51 – 169.59 Mb Chr 1: 163.98 – 164.05 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Coagulation factor V (Factor V), also less commonly known as proaccelerin or labile factor, is a protein involved in ...
Factor V Leiden is an inherited blood clotting disorder. It can cause life-threatening clots in the body and complications during pregnancy. What you need to know about factor V Leiden - a blood ...
The exact prevalence of protein S deficiency in the population is unknown; it is found 1.3–5% of people with thrombosis. [14] The minor ("type 2") thrombophilias are much more common. Factor V Leiden is present in 5% of the population of Northern European descent, but much rarer in those of Asian or African extraction.
There have also been cases in patients with other deficiency, including protein S deficiency, [6] [7] activated protein C resistance (Factor V Leiden) [8] and antithrombin III deficiency. [ 9 ] Although the above hypothesis is the most commonly accepted, others believe that it is a hypersensitivity reaction or a direct toxic effect.
The family of an American killed when a Malaysian Airlines plane was shot down over Ukraine in 2014 can sue Russia's largest bank for allegedly providing money transfers to a group blamed for ...
Heterozygous for factor V Leiden mutation; Heterozygous for factor II mutation; Overweight, in this case defined as a BMI > 28 at early pregnancy [9] Caesarean section; DVT heredity in a first-degree relative; Age > 40 years; Pre-eclampsia; Hyperhomocysteinemia; 2 points Intermediate risk factors: Protein S or protein C deficiency
Ad
related to: heterozygous factor v leiden deficiency